Translate this page into:
Caffeine derivatives as promising multi-target anti-Alzheimer’s agents: Investigating dual inhibition of AChE and BChE
*Corresponding author: E-mail address: sofia.zazouli@usms.ma (S Zazouli)
-
Received: ,
Accepted: ,
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory impairment and cognitive decline, largely associated with reduced acetylcholine levels in the brain. Targeting the enzymes responsible for acetylcholine degradation, AChE and BChE remains a central therapeutic strategy for symptomatic management. In this context, a novel series of caffeine-based derivatives incorporating biologically relevant pyridine moieties was rationally designed based on structural features essential for AChE and BChE inhibition. The compounds were efficiently synthesized via nucleophilic substitution reactions between theophylline and halogenated pyridine intermediates under microwave-assisted conditions, which significantly reduced reaction time and enhanced yields up to 95%. Structural elucidation was confirmed by fourier transform infrared (FTIR), nuclear magnetic resonance (NMR), and mass spectrometric (MS) analyses, further supported by density functional theory (DFT) calculations. Molecular electrostatic potential (MEP) mapping was performed to identify electrophilic and nucleophilic regions, while while highest occupied molecular orbital–lowest unoccupied molecular orbital (HOMO–LUMO) energy gap analysis and related quantum descriptors provided insight into charge transfer behavior and molecular stability. Natural bond orbital (NBO) and mulliken charge analyses were also employed to elucidate the electronic distributions within the molecules. Additionally, the synthesized derivatives showed preferential inhibition of BChE, with compound 3d exhibiting the most potent activity (IC50 = 7.87 ± 0.04 μM). This BChE selectivity contrasts with galantamine, a standard AChE inhibitor, and was further validated through molecular docking studies, which revealed favorable and specific binding interactions within the BChE active site. Computational ADMET (absorption, distribution, metabolism, excretion, & toxicity) predictions also indicated good oral bioavailability and a favorable safety profile, highlighting the potential of these novel molecules as selective cholinesterase inhibitors with promising pharmacokinetic properties for Alzheimer’s therapy.
Keywords
Caffeine derivatives
Cholinesterase inhibition
DFT calculations
In silico studies
Microwave-assisted synthesis
1. Introduction
Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by the progressive degeneration of neurons and atrophy in critical brain regions, leading to profound impairments in memory, language, behavior, and cognitive functions, as well as notable personality changes (Hosseini et al., 2024). A hallmark of AD pathology is the depletion of acetylcholine (ACh), a neurotransmitter essential for cognitive functions (Yang et al., 2023). This depletion results from the dysregulated cholinergic neurotransmission, primarily mediated by cholinesterase (ChE) enzymes. Inhibition of acetylcholinesterase (AChE) effectively increases ACh levels in the synaptic cleft, making cholinesterase inhibitors (ChEIs) the cornerstone of symptomatic AD therapy (Marucci et al., 2021). However, butyrylcholinesterase (BChE), another key enzyme involved in cholinergic regulation, becomes increasingly significant in the advanced stages of AD as AChE activity declines and BChE activity compensatorily increases (Greig et al., 2002). BChE plays a complementary role in maintaining cholinergic function by hydrolysis ACh (Greig et al., 2005). Consequently, dual AChE/BChE inhibition has emerged as a promising therapeutic approach to enhance cholinergic transmission across disease stages and provide broader symptomatic relief (Košak et al., 2025).
The growing global prevalence of AD, largely driven by an aging population, presents a major socioeconomic and healthcare challenge. With dementia cases projected to reach approximately 152 million by 2050 (Nasab et al., 2024), the urgent need for novel therapeutic interventions is evident. Currently approved AD treatments, such as tacrine, donepezil, rivastigmine, and galantamine, act primarily as AChE inhibitors to mitigate symptoms; however, they do not alter disease progression and are limited by moderate efficacy and undesirable side effects (Cummings et al., 2014; Ghezzi et al., 2013). These limitations underscore the necessity for developing new, safe, and more effective therapeutic agents.
Recent investigations have highlighted the therapeutic potential of non-traditional bioactive scaffolds, notably caffeine, which exhibits multifaceted neuroprotective properties (Cao et al., 2009; Arendash & Cao, 2010; Eskelinen & Kivipelto, 2010; Wostyn et al., 2011; Yoshimura, 2005; Cao et al., 2012; Carman et al., 2014). Caffeine exerts its neuroprotective effects primarily through antagonism of adenosine receptors, particularly the A2A receptor subtype, modulating neuronal signaling pathways, enhancing synaptic plasticity, and attenuating neuroinflammatory responses (Lopes et al., 2019). Moreover, caffeine mitigates amyloid-beta (Aβ) plaque accumulation, a pathological hallmark of AD (Cao et al., 2009; Arendash et al., 2006; Arendash et al., 2009) and demonstrates antioxidant (Ősz et al., 2022; Vieira et al., 2020) and mitochondrial protective effects (Dragicevic et al., 2015). It also upregulates neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF), which supports neuronal survival, synaptic integrity, and cognitive function (Sallaberry et al., 2013; Ghoneim et al., 2015). Importantly, caffeine has been reported to inhibit AChE activity directly (Fabiani et al., 2018).
Building upon these findings, Fabiani et al. 2022 (Fabiani et al., 2022) synthesized caffeine-pyrrolidine hybrids that exhibited potent AChE inhibitory activity and nicotinic acetylcholine receptor (nAChR) activation. Other structurally modified caffeine derivatives have demonstrated even greater potency as AChE inhibitors compared to previously reported caffeine-pyrrolidine hybrids (Biscussi & Murray, 2022). Furthermore, caffeine-based triazole derivatives synthesized by Sharma et al. (2022) displayed dual inhibitory activity against both ChE and β-site amyloid precursor protein cleaving enzyme-1 (BACE-1). Despite these advancements, the structure-activity relationship (SAR) of caffeine and its derivatives remain insufficiently explored, particularly regarding their interactions with cholinergic enzymes and their broader pharmacological profiles.
In this work, we designed and synthesized a new series of bifunctional caffeine derivatives incorporating pyridine units to enhance pharmacological potential. Pyridine, a versatile heterocyclic scaffold, is well-recognized for its inclusion in numerous bioactive molecules exhibiting activities such as Aβ aggregation inhibition (Zhu et al., 2019; Pandolfi et al., 2017; Vidali et al., 2022), AChE inhibition (Saeedi et al., 2020; Arslan et al., 2019; Zhou et al., 2019), and antioxidant effects (Hatanaka et al., 2005; Fadda et al., 2012; Kahriman et al., 2013; Li et al., 2017; Kaddouri et al., 2020). Although compounds 3a and 3d were previously reported in metal complexation studies (Bevilacqua et al., 2022; Tsai et al., 2019), their biological activities remain unexplored. Here, we investigate four N7-substituted caffeine derivatives as potential ChEI relevant to AD. Their structural, electronic, and binding characteristics are systematically examined through a combination of computational modeling, in vitro enzymatic assays, and molecular docking analyses. By addressing the current gap in caffeine-based therapeutic design, this study elucidates the influence of targeted structural modifications on enzyme selectivity and bioactivity, advancing the discovery of promising ChE inhibitors for AD management.
2. Materials and Method
2.1 Chemicals and materials
All solvents and reagents used in this study for synthesizing the caffeine derivatives under investigation were used as received unless stated otherwise. The melting points (m.p) of the obtained compounds were determined using open capillary tubes and are reported without correction. 1H (400 MHz) and 13C (100 MHz) nuclear magnetic resonance (NMR) spectra were recorded at 25°C on Bruker AV300 or AV500 spectrometers using deuterated solvents, with residual solvent peaks serving as internal reference. Fourier-transform infrared (FT-IR) spectra were obtained using a micrOTOF II spectrometer over the 4000-400 cm-1 range. Electrospray ionization mass spectrometric (ESI–MS) analyses were performed in positive ionization mode using a micrOTOF liquid chromatography (LC)/MS spectrometer. Elemental analyses were determined on a Thermo Scientific Flash 2000 analyzer. All chemical shifts (δ) are expressed in parts per million (ppm).
2.2 Synthesis of compounds 3a-c
The synthesis of compounds 3a-c was carried out following the procedure described by Tsai et al, 2019 (Tsai et al., 2019) with minor adjustments. Scheme 1 illustrates the general synthetic route for the preparation of the target derivatives. Theophylline (1.3 g, 7.2 mmol) and potassium carbonate (3.38 g, 24.4 mmol) were suspended in N, N-dimethylformamide (40 mL) under argon and stirred for 15 min at room temperature. Subsequently, 2-(Chloromethyl)-pyridine hydrochloride or 3-(Chloromethyl)-pyridine hydrochloride or 4-(Chloromethyl)-pyridine hydrochloride (1 g, 6 mmol) was added to the reaction mixture. The resulting suspension was subjected to microwave irradiation (MW) at 130°C for 25 min (300 W, standard mode) with a 5 min ramp to the target temperature and moderate stirring (Vinuesa et al., 2022). This modification significantly improved the efficiency of the reaction compared with the conventional multi-hour reflux reported by Tsai et al. (2019), enabling the direct use of chloromethylpyridine hydrochlorides without pre-halogenation, and eliminating the need for metal catalysts or complex extraction procedures. Upon completion, N, N-dimethylformamide was removed under reduced pressure, and water (10 mL) was added to precipitate the product. The resulting solid was collected by filtration, washed sequentially with water (2×10 mL), MeOH (2×5 mL), and Et2O (2×5 mL). The products were obtained as pure white powders, except for 3c, which required purification by silica column using CH2Cl2 as the initial eluent, gradually transitioning to CH2Cl2/MeOH (95:5, v/v).

- Synthesis routes of synthesized compounds.
2.2.1 1,3-dimethyl-7-[(pyridin-3-yl)methyl]-1H-purine-2,6-dione (3a)
White solid. Yield: 88%. MS (ESI): m/z = 294.10 [M + Na]+, calculated m/z= 271.11. IR (νmax/cm–1) 3094 (CH), 1695 (C=O), 1625 (C=C), 1563 (C=N). 1H NMR (CD3Cl, 500 MHz): δ 8.56 (d, J = 4.5 Hz, 1H, H22), 7.84 (s, 1H, H27 theophylline), 7.70 (td, J1= 2 Hz, J2 = 7 Hz, 1H, H24), 7.44 (d, J = 4.5 Hz, 1H, H23), 7.25 (td, J1= 1 Hz, J2 = 4.5 Hz, 1H, H21), 5.60 (s, 2H, CH2, H25, H26), 3.60 (s, 3H, CH3, H31, H32, H33), 3.40 (s, 3H, CH3, H28, H29, H30). 13C NMR (CDCl3, 125 MHz) δ: 155.3 (C4), 154.6 (C16), 151.7 (C14), 149.8 (C2), 148.8 (C11), 141.8 (C9), 137.3 (C6), 123.4 (C5), 122.8 (C1), 106.7 (C12), 51.5 (C8), 29.8 (C20), 28.0 (C19). Elemental analysis (%) calc for C13H13N5O2: C 57.56; H 4.83; N 25.82. Found: C 57.51; H 4.86; N 25.78.
2.2.2 1,3-dimethyl-7-[(pyridin-4-yl)methyl]-1H-purine-2,6-dione (3b)
White solid. Yield: 65%. MS (ESI): m/z = 272.11 [M + H]+, calculated m/z = 271.11. IR (νmax/cm–1) 3125 (CH), 1695 (C=O), 1628 (C=C), 1563 (C=N). 1H NMR (CD3Cl, 500 MHz): δ 8.60 (s, 1H, H22), 8.55 (d, J= 4.5 Hz, 1H, H21), 7.68 (d, J = 8.5 Hz, 1H, H23), 7.60 (s, 1H, H27 theophylline), 7.22 (dd, J1= 4.5 Hz, J2 = 8.5 Hz, 1H, H24), 5.50 (s, 2H, CH2, H25, H26), 3.55 (s, 3H, CH3, H31, H32, H33), 3.36 (s, 3H, CH3, H28, H29, H30). 13C NMR (CDCl3, 125 MHz) δ: 155.2 (C16), 151.5 (C14), 150.0 (C3), 149.2 (C1), 148.9 (C11), 140.7 (C9), 135.7 (C4), 131.2 (C5), 123.8 (C6), 106.7 (C12), 47.7 (C8), 29.8 (C20), 28.0 (C19). Elemental analysis (%) calc for C13H13N5O2: C 57.56; H 4.83; N 25.82. Found: C 57.60; H 4.89; N 25.84.
2.2.3 1,3-dimethyl-7-[(pyridin-2-yl)methyl]-1H-purine-2,6-dione (3c)
White solid. Yield: 66%. MS (ESI): m/z = 272.11 [M + H]+, calculated m/z = 271.11. IR (νmax/cm–1) 3109 (CH), 1687 (C=O), 1625 (C=C), 1570 (C=N). 1H NMR (CD3Cl, 500 MHz): δ 8.68 (d, J= 4 Hz, 2H, H21, H24), 7.73 (s, 1H, H27 theophylline), 7.23 (d, J = 4 Hz, 2H, H22, H23), 5.60 (s, 2H, CH2, H25, H26), 3.68 (s, 3H, CH3, H31, H32, H33), 3.46 (s, 3H, CH3, H28, H29, H30). 13C NMR (CDCl3, 125 MHz) δ: 155.2 (C16), 154.4 (C14), 151.6 (C2, C6), 148.8 (C11), 142.0 (C4), 139.0 (C9), 122.4 (C3, C5), 106.6 (C12), 50.6 (C8), 29.9 (C20), 27.9 (C19). Elemental analysis (%) calc for C13H13N5O2: C 57.56; H 4.83; N 25.82. Found: C 57.58; H 4.89; N 25.78.
2.3 Synthesis of compound 3d
Compound 3d was synthesized following the procedure reported by Bevilacqua et al. 2022 with minor modifications. Scheme 1 depicts the general synthetic route employed for synthesizing the target compound. Under argon, theophylline (0.82 g, 4.5 mmol) and potassium carbonate (1 g, 7.2 mmol) were suspended in N, N-dimethylformamide (30 mL) and stirred for 15 min at room temperature. Subsequently, 2, 6-Bis(bromomethyl)pyridine (1 g, 1.9 mmol) was added to the reaction mixture. The resulting suspension was subjected to MW at 130°C for 20 min (300 W, standard mode) with a 5 min ramp to the target temperature and moderate stirring (Vinuesa et al., 2022). This modification effectively replaced the conventional multi-day heating reported in Bevilacqua et al. 2022, which employed Cu(I) catalysis, sodium ascorbate, and phenanthroline in a DMF/H₂O solvent mixture at 120°C for 3 days. Following completion of the reaction, N, N-dimethylformamide was removed under reduced pressure, and water (10 mL) was added. The resulting precipitate was collected by filtration, washed successively with water (2×10 mL), followed by MeOH (2×5 mL) and Et2O (2×5 mL).
2.3.1 1,3-dimethyl-7-[(4-{[2-(3,7-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-1,3,7-triazin-1-yl)ethyl]amino}pyrimidin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione (3d)
White solid. Yield: 95%. MS (ESI): m/z = 464.17 [M + H]+, calculated m/z = 463.17. IR (νmax/cm–1) 3125 (CH), 1669 (C=O), 1687 (C=C), 1570 (C=N). 1H NMR (CD3Cl, 500 MHz): δ 7.75 (t, J= 8 Hz, 1H, H37), 7.73 (s, 2H, H40, H50 theophylline), 7.41 (d, J = 8 Hz, 2H, H35, H36), 5.56 (s, 4H, CH2, H38, H39, H48, H49), 3.61 (s, 6H, CH3, H44, H45, H46, H54, H55, H56), 3.36 (s, 6H, CH3, H41, H42, H43, H51, H52, H53). 13C NMR (CDCl3, 125 MHz) δ: 155.1 (C2, C4), 151.6 (C16, C27), 150.5 (C14, C29), 149.0 (C11, C24), 144.3 (C9, C26), 141.0 (C6), 121.9 (C1, C5), 106.8 (C12, C23), 49.0 (C8, C21), 29.9 (C20, C34), 28.0 (C19, C33). Elemental analysis (%) calc for C21H21N9O4: C, 54.42; H, 4.57; N, 27.20. Found: C 54.41; H 4.58; N 27.20.
2.4 Theoretical details
The molecular geometry optimization of the title compounds was performed using density functional theory (DFT) at the B3LYP/6-311G (d,p) level of theory, implemented in the Gaussian 09 software package (Frisch et al., 2009). Visualization and analysis of the optimized structures were conducted using the GaussView 6.0 (Frish et al., 2016). The ground-state geometries of all compounds were fully optimized without symmetry constraints, and key structural parameters, including bond lengths and bond angles, were calculated. Frontier molecular orbital (FMO) energies, namely the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO), were determined to evaluate the electronic properties and chemical reactivity of the compounds. Additionally, Mulliken atomic charge distribution, natural bond orbital (NBO) analysis, and molecular electrostatic potential (MEP) mapping were carried out to identify potential reactive sites and gain further insight into the electronic structure.
2.5 Biological evaluation
2.5.1 In vitro AChE and BChE inhibition assays
The ChEI activities of the synthesized compounds were evaluated against AChE and BChE following the protocols provided with commercially available kits. Stock solutions of the test compounds were prepared in high concentration and serially diluted in the corresponding assay buffer, with galantamine employed as the reference inhibitor. For AChE inhibition, 10 µL of 20X diluted samples was added to each well of a 96-well microplate, followed by 10 µL of enzyme solution and the chromogenic substrate mixture. The absorbance was monitored at 412 nm for 40 min at room temperature (Ellman et al., 1961). BChE inhibition was assessed in black 96-well plates by combining 100 µL of each test solution with 50 µL of a fluorescent reagent containing butyrylthiocholine. After a 20 min incubation, fluorescence intensity was recorded at excitation and emission wavelengths of 390 nm and 510 nm, respectively (Soliman et al., 2023; Gabr & Brogi, 2020). All experiments were conducted in triplicate, and IC₅₀ values were calculated using non-linear regression after background correction. Statistical analyses were performed using GraphPad Prism software (version 9.0.1) (GraphPad Software, San Diego, California, USA). One-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test was applied to determine statistically significant differences between the tested compounds and the reference standard. A p < 0.05 was considered statistically significant.
2.5.2 Docking study
To evaluate the synthesized compounds as potential ChEI, molecular docking studies were performed against AChE (PDB ID: 4M0E) and BChE (PDB ID: 1P0P) (Ullah et al., 2024). Protein structures were prepared using AutoDockTools, wherein all crystallographic water molecules and co-crystallized ligands were removed, followed by the addition of polar hydrogen atoms and assignment of Gasteiger partial charges. The ligand structures were generated using ChemDraw, then geometry-optimized at the DFT/B3LYP/6-311G(d,p) level prior to docking. Docking simulations were carried out in PyRx (v0.8) (Kondapuram et al., 2021; Chandramohan et al., 2023) employing AutoDock Vina (v1.5.7) (Trott & Olson, 2009), with energy minimization executed under default parameters. The optimal binding conformations were selected based on the lowest binding free energy and key molecular interactions within the active site. Visualization and interaction analyses of ligand-protein complexes were performed using Discovery Studio Visualizer (v21.1.0.20298) (Dassault Systèmes 2021).
2.5.3 ADME-T prediction
Computational predictions of the pharmacokinetic properties of the newly synthesized compounds were performed using the SwissADME online server to evaluate absorption, distribution, metabolism, and excretion (ADME) profile (Daina et al., 2017). Additionally, the potential toxicity of these compounds was assessed using the ProTox-II platform (Banerjee et al., 2018).
3. Results and Discussion
3.1 Chemistry
Compounds 3a-d were synthesized via a nucleophilic substitution reaction, in which potassium carbonate deprotonates the nitrogen atom of theophylline, enhancing its nucleophilicity. This activated electrophile attacks the electrophilic carbon of the chloromethyl-pyridine derivative, resulting in the displacement of the chloride ion. DMF was employed as the solvent to stabilize the transition state and facilitate the substitution process. MW-assisted heating was applied to improve reaction efficiency, significantly reducing the reaction time to 25 min. Although this methodology follows a well-established synthetic pathway, the primary objective of this study is the pharmacological evaluation of these novel derivatives, whose biological activities have not been previously reported. The structures of compounds 3a-d were confirmed through comprehensive spectroscopic analysis, including 1H and 13C NMR, IR, and mass spectrometry (See supporting information).
3.2.1 1H and 13C NMR spectral analysis
RMN spectroscopy is a powerful analytical tool for elucidating the structural and functional characteristics of molecules, providing detailed insights into their chemical environments. The DFT has proven particularly valuable for predicting NMR spectra accurately, facilitating the correlation between molecular structure and chemical shifts (Zazouli et al., 2022). In this study, the 1H and 13C NMR chemical shifts of the newly synthesized compounds were computed at the B3LYP/6-311G(d,p) level of theory. The optimized geometries with atomic numbering of 3a-d have been illustrated in Supplementary file. Tables S1 and S2 present the experimental and calculated chemical shifts, demonstrating a strong agreement and confirming consistency with the proposed molecular structure (See Supporting Info).
The experimental 1H NMR chemical shifts for aromatic protons in compounds 3a-d were observed in the range of δ 8.69 to 7.22 ppm in CDCl₃, whereas the corresponding theoretical values ranged from δ 8.81 to 6.36 ppm. The observed consistency across the compounds reflects the influence of the nitrogen atom within the pyridine moiety, particularly in compounds 3a-c, which differ in para, meta, and ortho positioning relative to the theophylline scaffold. In contrast, compound 3d lacks protons adjacent to the pyridine nitrogen, accounting for a notable difference in its proton chemical shifts.
Specifically, for proton H17, the experimental chemical shifts were δ 7.80, 7.61, 7.73, and 7.69 ppm for compounds 3a, 3b, 3c, and 3d, respectively, while the theoretical values were δ 7.31, 6.73, 6.75, and 5.10 ppm. In the aliphatic region, comparable 1H NMR signals were observed across all derivatives. For instance, three singlet signals appeared at δ 5.60 (for CH₂ protons H25 and H26), δ 3.60 (for CH₃ protons H31, H32, and H33), and δ 3.40 (for CH₃ protons H28, H29, and H30). The corresponding calculated chemical shifts were δ 5.08-5.30 for CH₂ (H25, H26), δ 3.19-3.51 for CH₃ (H31, H32, H33), and δ 3.57-3.55 for CH₃ (H28, H29, H30). In certain cases, significant discrepancies between experimental and theoretical values were observed. Minor discrepancies between experimental and theoretical values are attributed to the free rotation of methyl groups in theophylline moiety and the CH₂ linkers connecting the pyridine and theophylline moieties in the experimental solution, which introduce conformational flexibility not fully captured by theoretical calculations.
For the 13C NMR spectra, experimental chemical shifts ranged from δ27.9 to 155.3 ppm in CDCl₃, while theoretical values calculated at B3LYP/6-311G(d,p) spanned δ20.55 to 159.45 ppm. Notably, carbon atoms adjacent to electronegative atoms, such as oxygen (carbonyl) and nitrogen (pyridine), exhibited consistently higher chemical shifts due to the deshielding effect induced by electron-withdrawing. The close agreement between experimental and theoretical 13C chemical shifts further supports the validity of the calculated structures.
Aromatic protons exhibited resonance signals between δ7.18 and 7.50 ppm experimentally, and between δ7.39 and 7.92 ppm theoretically. The observed discrepancies are likely due to intermolecular hydrogen bonding interactions, which are not fully accounted for in the theoretical calculations. Modeling the dimeric form of these compounds could further improve the agreement between experimental and theoretical chemical shifts.
3.2.2 Vibrational assignment
FTIR spectroscopy is a widely employed technique for characterizing chemical bonds and functional groups in molecular structures. The vibrational assignments, experimental frequencies, theoretical wavenumbers, and calculated infrared intensities of the synthesized compounds have been summarized in Table S3. The symmetric and asymmetric C-H stretching vibrations typically appear between 3100 and 3000 cm-1 (Stuart, 2004; Larkin, 2018). In the experimental IR spectra, these bands were observed at 3094, 3125, 3109, and 3125 cm-1 for compounds 3a-d, respectively, while the corresponding theoretical values were calculated in the range of 3209-3184, 3204-3162, 3199-3179, and 3205-3118 cm-1.
Asymmetric and symmetric CH₂ stretching vibrations typically occur between 3000 and 2850 cm-1 (Abraham et al., 2018). The symmetric CH₂ stretches were experimentally observed at 2938 and 2937 cm-1 for 3a & 3b and 3c & 3d, respectively, in good agreement with theoretical predictions of 3126, 3127, 3165, and 3095 cm-1.
The carbonyl (C=O) stretching vibration typically occurs between 1650 and 1800 cm-1, a region minimally affected by other absorptions, facilitating its identification. In the experimental spectra, the symmetric C=O stretches were detected at 1695-1687 cm-1 for compounds 3a-d, while theoretical values were calculated as 1669-1669 cm-1. This minor discrepancy is likely due to strain within the heterocyclic ring system, providing insights into the geometry of the carbonyl-containing ring.
C=C stretching vibrations within aromatic rings generally appear in the range 1675 to 1500 cm-1. Experimentally, these were observed at 1625 cm⁻1 for compound 3a, 1628 cm⁻1 for 3b, and 1687 cm⁻1 for compounds 3c and 3d, which align closely with the calculated values of 1638, 1639, 1668, and 1669 cm⁻1 for compounds 3a, 3b, 3c, and 3d, respectively. C=N stretching vibrations, typically occurring between 1700 and 1500 cm⁻1 (Ermiş et al., 2018), were experimentally measured at 1563 cm⁻1 for compound 3a, 1577 cm⁻1 for 3b, and 1570 cm⁻1 for compounds 3c and 3d, with corresponding theoretical values of 1598, 1599, 1639, and 1609 cm⁻1 for compounds 3a, 3b, 3c, and 3d, respectively. These results are consistent with symmetric C=N stretching vibrations reported in related studies (Tamer et al., 2014; Evecen et al., 2025).
3.2.3 FMO analysis
FMO analysis provided critical insights into the electronic properties and chemical reactivity of the investigated compounds. As illustrated in Supplementary file, the HOMO and LUMO orbitals of compounds 3a-c are delocalized throughout the molecular framework, whereas in compound 3d, the HOMO is predominantly localized on the caffeine moiety. Notably, compound 3d exhibited the smallest HOMO-LUMO energy gap (ΔEGAP) and the lowest chemical hardness, indicating higher chemical reactivity and reduced thermodynamic stability. It also demonstrated increased electron transfer capability and polarizability. Additionally, 3d displayed the lowest electrophilicity index (ω = 0.107 eV) and a comparatively high dipole moment, further supporting its enhanced chemical reactivity (Table 1). Collectively, these results suggest that compound 3d is the most electronically active and potentially the most biologically relevant of the series (See supporting information).
| Global parameters | Values (eV) | |||
|---|---|---|---|---|
| 3a | 3b | 3c | 3d | |
| ET (eV) | -927.404 | -927.397 | -927.397 | -1607.064 |
| EHOMO (eV) | -0.239 | -0.238 | -0.240 | -0.224 |
| ELUMO (eV) | -0.059 | -0.057 | -0.059 | -0.055 |
| ΔE(LUMO –HOMO) (eV) | 0.180 | 0.181 | 0.181 | 0.169 |
| Chemical hardness (η) | 0.090 | 0.091 | 0.091 | 0.085 |
| Chemical Softness (s) | 0.045 | 0.046 | 0.045 | 0.042 |
| Chemical potential (µ) | 0.149 | 0.148 | 0.149 | 0.135 |
| Electrophilicity (ω) | 0.122 | 0.121 | 0.121 | 0.107 |
| Electronegativity (χ) | -0.149 | -0.148 | -0.149 | -0.135 |
| Dipole moment (D) | 4.068 | 6.278 | 4.303 | 5.510 |
η=1/2[ELUMO–EHOMO], s =1/2η, µ= – [1/2(ELUMO+EHOMO)], ω = µ2/2η, χ = –µ
3.2.4 Mulliken atomic charges
As depicted in Figs. S1-S28 (Supporting information), the electronic distribution in the synthesized compounds is strongly influenced by the functional groups and heterocyclic ring systems. The carbon atoms C14 and C16 serve as principal electrophilic centers, while the nitrogen atoms in the pyridine moiety represent key nucleophilic sites. Notably, the pronounced negative charge on N3 in compound 3d further indicates its potential for strong intermolecular interactions, which may contribute to the enhanced bioactivity observed for this derivative (See supporting information).
3.2.5 NBO
The NBO analysis revealed that the synthesized compounds exhibit significant intramolecular charge transfer (ICT) and electron delocalization, predominantly mediated through key bonding interactions and lone pairs. These electronic interactions contribute to the overall stabilization of the molecular systems. Among the series, compound 3d displayed the highest stabilization energies, indicating enhanced electronic delocalization and suggesting potentially greater chemical reactivity and bioactivity. The summarized NBO results have been presented in Table S4 and further detailed in the Supporting Information.
3.2.6 MEP
The synthesized compounds 3a-d exhibit pronounced polarity and chemical reactivity, which are critical for effective interactions with biological targets. As illustrated in Supplementary file, regions of high negative electrostatic potential are localized on the carbonyl and amine groups, indicating their potential significance in binding through electrophilic interactions. Conversely, areas of positive electrostatic potential on hydrogen atoms highlight possible sites for nucleophilic attack (See supporting information).
3.3 Biological evaluation
3.3.1 In vitro AChE and BChE inhibitory activities
As summarized in Table 2, the tested compounds consistently demonstrated preferential inhibition of BChE over AChE. Among the series, compound 3d emerged as the most potent BChE inhibitor (IC50 = 7.87 ± 0.04 μM) while exhibiting moderate AChE inhibition (IC50 = 39.15 ± 0.26 μM), indicating the highest selectivity for BChE. Compounds 3a-c displayed comparatively lower inhibitory activity but maintained greater efficacy against BChE than AChE. In contrast, the reference drug galantamine selectively inhibited AChE. Statistical analysis confirmed that compound 3d was significantly more potent against BChE than all other derivatives, whereas both 3d and galantamine were markedly more active against AChE relative to the remaining compounds. This selective inhibition profile highlights the potential of these compounds as therapeutic candidates targeting BChE-mediated pathways, which is particularly relevant in the later stages of Alzheimer’s disease when BChE activity rises as AChE activity declines (See Supporting Information for more detailed information).
| Compound | IC50 (μM) | Selectivity Index BChE IC50/AChE IC50 | |
|---|---|---|---|
| AChE | BChE | ||
| 3a | 71.32± 0.14c | 20.09± 0.01b | 0.513 |
| 3b | 91.27± 3.8d | 27.33± 0.08c | 0.299 |
| 3c | 84.34± 1.7d | 32.72± 0.9c | 0.387 |
| 3d | 39.15±0.26b | 7.87± 0.04a | 0.201 |
| Galantamine | 28.52± 0.09a | 52.39± 0.21d | 1.536 |
IC50 values (mean ± standard error of mean), a, b, c, d indicate statistically significant differences (p < 0.05, Tukey’s test)
3.3.2 AChE and BChE inhibitory activity in silico docking
Molecular docking analysis represents a pivotal tool in drug discovery, providing detailed insights into the interactions between potential drug candidates and their target proteins at the molecular level (Pinzi & Rastelli, 2019). The 2D and 3D interaction profiles of the synthesized compounds within the active sites of AChE and BChE have been illustrated in Fig. 1 and 2, with binding energies and rankings presented in Table 3. Galantamine served as a positive control to benchmark the binding affinities of the tested compounds.

- The molecular docking 2D and 3D interactions between compounds 3a-d and the active site of 4M0E.

- The molecular docking 2D and 3D interactions between compounds 3a-d and the active site of 1P0P.
| Proteins | Compound no. | Docking score (kcal/mol) | No. of H-bonds | H-bonding residues |
|---|---|---|---|---|
| 4M0E | 3a | -7.4 | 4 | HIS405, ASN233, ASN533 |
| 3b | -7.1 | 3 | ASN533, ASN233, HIS405 | |
| 3c | -7.2 | 4 | HS405, ASN233, ASN533 | |
| 3d | -8.2 | 4 | HIS405, ARG296, PRO235. | |
| Galantamine | -8.6 | 1 | TYR72 | |
| 1P0P | 3a | -8.9 | 1 | GLU197 |
| 3b | -8.6 | 1 | GLU197 | |
| 3c | -8.4 | 2 | GLU197, ALA328 | |
| 3d | -11.0 | 4 | LEU286, THR120, GLY287, THR120 | |
| Galantamine | -9.7 | 3 | TYR128, GLU197, HIS438 |
Across all compounds, the carbonyl group of the caffeine moiety consistently engaged in hydrogen bonding with key residues, including HIS405, GLU197, and THR120. The amine functionalities on the pyrimidine and imidazole rings acted as principal hydrogen bond donors, most prominently in compound 3d, which formed multiple polar contacts with residues including Arg296, Leu286, and Gly287. Aromatic and heterocyclic rings, including pyridine, imidazole, and purine scaffolds, participated in π-alkyl and π-π stacking interactions, further stabilizing the ligand-protein complexes. Notably, compound 3d exhibited the most diverse and extensive interaction network, combining strong hydrogen bonding and hydrophobic interactions, which likely underpins its superior binding affinity. Therefore, the observed interactions for compound 3d, including multiple hydrogen bonds and hydrophobic contacts, provide meaningful insights into its potential bioactive conformation, although future MD simulations may further refine these predictions.
These findings underscore the importance of combining polar and hydrophobic groups within a molecule to optimize binding efficiency and selectivity toward cholinesterase enzymes (See supporting information).
3.3.3 In silico ADME-T studies
In silico ADME analysis was conducted, representing a crucial component of early drug discovery by providing predictions of compound behavior in an in vivo environment (Özkay et al., 2017). Additionally, toxicity parameters were evaluated, with the combined results summarized in Table 4. All compounds exhibited favorable drug-like properties, including moderate lipophilicity (log P = 0.20-0.57), optimal topological polar surface area (TPSA = 74.47-136.53 Å2), and molecular weights compatible with oral bioavailability. The compounds also complied with Lipinski’s and Veber’s rules and displayed a favorable bioavailability score of 0.55. Importantly, compounds 3a-c were not predicted to be P-gp substrates, suggesting enhanced oral absorption and tissue distribution. Regarding metabolic stability, compounds 3a-c were predicted to inhibit CYP1A2, whereas compound 3d inhibited CYP3A4, indicating potential drug-drug interaction risks. All compounds were predicted to be non-toxic (See Supporting Info for full details).
| Properties | Derivatives | |||
|---|---|---|---|---|
| 3a | 3b | 3c | 3d | |
| MWa (≤500) | 271.27 | 271.27 | 271.27 | 463.45 |
| TPSAb (Å2) | 74.71 | 74.71 | 74.71 | 136.53 |
| HBAc (≤10) | 4 | 4 | 4 | 7 |
| HBDd (≤5) | 0 | 0 | 0 | 0 |
| Bioavailability | 0.55 | 0.55 | 0.55 | 0.55 |
| nRotBe (≤5) | 2 | 2 | 2 | 4 |
| Log Pf (≤5) | 0.57 | 0.52 | 0.52 | 0.20 |
| Lipinski violations | Yes 0 | Yes 0 | Yes 0 | Yes 1 |
| ilog (PO/W)i (<5) | 2.25 | 2.06 | 2.05 | 3.11 |
| Mlog(PO/W)j (<5) | 0.25 | 0.25 | 0.25 | 0.47 |
| GI absorption | High | High | High | Low |
| BBB permeant | NO | NO | NO | NO |
| log Kph (cm/s) | -7.88 | -7.91 | -7.91 | -9.55 |
| MRg | 74.32 | 74.32 | 74.32 | 124.41 |
| P-gp substrate | NO | NO | NO | Yes |
| CYPIA2 inhibitor | Yes | Yes | Yes | No |
| CYP2C19 inhibitor | NO | NO | NO | NO |
| CYP2C9 inhibitor | NO | NO | NO | NO |
| CYP2D6 inhibitor | NO | NO | NO | NO |
| CYP3A4 inhibitor | NO | NO | NO | Yes |
| Carcinogenicity | NO | NO | NO | NO |
| Mutagenicity | NO | NO | NO | NO |
| Cytotoxicity | NO | NO | NO | NO |
aMolecular weight; bTopological polar surface area; cNumber of hydrogen bond acceptor; dNumber of hydrogen bond donor; eNumber of rotatable bonds; fConsensus of calculated lipophilicity; gMolar Refractivity; hskin permeation; ioctanol-water partition coefficient; jMoriguch iLogP (octanol-water partition).
3.3.4 Gastrointestinal absorption and Brain penetration prediction [BOILED-Egg]
The BOILED-Egg model provides a straightforward computational approach for predicting a compound’s potential of gastrointestinal (GI) absorption and blood-brain barrier (BBB) penetration, based on polarity and lipophilicity. This assessment is particularly relevant for evaluating the oral bioavailability and central nervous system accessibility of candidate therapeutics for Alzheimer’s disease. According to the BOILED-Egg predictions summarized in Supplementary File, compounds 3a-c are located within the white region, indicating high GI absorption and favorable oral bioavailability, thereby supporting their potential as orally administered Alzheimer’s therapeutics. In contrast, compound 3d is located in the grey, suggesting limited GI absorption and poor passive BBB penetration. These results imply that, while 3d may exhibit reduced oral bioavailability and limited brain access through passive diffusion, alternative delivery strategies or structural modifications may be required to optimize its therapeutic efficacy in AD treatment.
3.4 Correlation of DFT parameters with biological activities and structure–activity relationships of novel cholinesterase inhibitors
DFT and NBO analyses revealed that the electronic features of the synthesized compounds strongly correlate with their biological activities. Compound 3d showed the lowest ΔEgap and highest electronic softness, indicating enhanced reactivity and stronger BChE binding, supported by multiple hydrogen bonds and π-π interactions. In contrast, 3a-c displayed larger ΔEgap values and weaker inhibition. Mulliken and MEP analyses confirmed that charge distribution at carbonyl and amine groups aligns with key binding regions, reinforcing the enzyme-ligand complementarity. The high dipole moment and favorable ADME-T profile of 3d further explain its selectivity and drug-likeness. Thus, increased conjugation and electron-withdrawing substituents enhance BChE inhibition and CNS activity, designating 3d as the most promising lead compound (See supporting information).
4. Conclusions
In this study, a series of caffeine derivatives incorporating pyridine cores was synthesized as potential anti-Alzheimer’s agents using a MW-assisted synthetic approach. This methodology enabled rapid and efficient synthesis, yielding high product quantities in significantly shorter times compared to conventional procedures. The structures of the synthesized compounds were confirmed using spectroscopic techniques, including 1H and 13C NMR, IR, and ESI-MS, complemented by computational studies employing DFT methods. Calculated molecular properties, vibrational frequencies, and chemical shift were compared with the corresponding experimental data to validate the computational models.
Electronic structure analysis through HOMO-LUMO energy calculations revealed that compound 3d possesses favorable chemical reactivity characteristics, highlighting it as a promising bioactive candidate. MEP surfaces were computed to identify potential active sites for chemical interactions, while Mulliken charge analysis delineated nucleophilic and electrophilic regions. NBO analysis further revealed significant hyperconjugative interactions and stabilization energies. The synthesized compounds also exhibited favorable drug-like properties in accordance with Lipinski’s guidelines.
Biological evaluation demonstrated that all compounds preferentially inhibited BChE over AchE; compound 3d exhibited the highest BChE inhibitory activity (IC50 = 7.87±0.04 μM) and the lowest selectivity index (0.201), indicating strong selectivity. In contrast, galantamine displayed greater AChE inhibition, consistent with its established pharmacological profile. Molecular docking studies corroborated these observations, revealing more extensive hydrogen bonding interactions between the synthesized compounds and the BChE active site compared to AChE, reinforcing their selective inhibitory profile. These results underscore the potential of the synthesized caffeine-pyridine derivatives as drug candidates and provide valuable insights for the rational design and development of novel therapeutics for AD.
Acknowledgments
This work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2601). The authors wish to express their sincere gratitude to Prof. Aziz JOUAITI for providing the spectroscopic analysis, which significantly enhanced the depth of our study.
CRediT authorship contribution statement
Sofia Zazouli: Conceptualization, methodology, software, validation, formal analysis, validation, investigation, data curation, writing original draft preparation, writing-review and editing, visualization. Fahd A. Nasr: Conceptualization, writing original draft preparation, writing-review and editing, Funding acquisition. Kawthar El Ahmadi: Methodology, investigation, data curation, writing original draft preparation. Salah Laaraj: Methodology, investigation, data curation, writing original draft preparation. Hasnae El Allaoui: Software, visualization. Mohamed El Bakkali: Software, data curation, visualization. El Hassania Loukili: Software, visualization. Atman Adiba: Investigation, data curation, writing-review and editing. Mohammed Al-Zharani: writing-review and editing, visualization, Funding acquisition. Ashraf Ahmed Qurtam: Writing-review and editing, visualization, Funding acquisition. Mohamed Bouhrim: Conceptualization, writing-review and editing, supervision, Project administration.
Declaration of competing interest
The authors declare that they have no competing financial interests or personal relationships that could have influenced the work presented in this paper.
Data availability
The original contributions presented in this study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding author(s).
Declaration of generative AI and AI-assisted technologies in the writing process
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Funding
This work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2601)
Supplementary Materials
The following supporting information includes both experimental and theoretical 1H and 13C-NMR spectra, IR spectra of the compounds, mass spectrometry data, optimized molecular structures with atom-labeling schemes, bond lengths, bond angles, and 3D molecular docking interactions between the compounds and target enzymes are available at https://dx.doi.org/10.25259/JKSUS_954_2025.
References
- Vibrational and electronic absorption spectroscopic profiling, natural hybrid orbital, charge transfer, electron localization function and molecular docking analysis on 3-amino-3-(2-nitrophenyl) propionic acid. J Mol Struct. 2018;1171:733-746. https://doi.org/10.1016/j.molstruc.2018.06.057
- [Google Scholar]
- Molecular docking and simulation studies of antiviral compounds against to fowl adenovirus type 4 receptor from – Psittacine bird – Melopsittacus undulates. Microb Pathog. 2023;181:106208. https://doi.org/10.1016/j.micpath.2023.106208
- [Google Scholar]
- Caffeine and coffee as therapeutics against Alzheimer’s disease. JAD. 2010;20:S117-S126. https://doi.org/10.3233/jad-2010-091249
- [Google Scholar]
- Caffeine reverses cognitive impairment and decreases brain amyloid-ß levels in aged Alzheimer’s disease mice. JAD. 2009;17:661-680. https://doi.org/10.3233/jad-2009-1087
- [Google Scholar]
- Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain ß-amyloid production. Neuroscience. 2006;142:941-952. https://doi.org/10.1016/j.neuroscience.2006.07.021
- [Google Scholar]
- Design, synthesis, characterization of peripherally tetra-pyridine-triazole-substituted phthalocyanines and their inhibitory effects on cholinesterases (AChE/BChE) and carbonic anhydrases (hCA i, II and IX) Dalton Trans. 2020;49:203-209. https://doi.org/10.1039/c9dt03897c
- [Google Scholar]
- ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46:W257-W263. https://doi.org/10.1093/nar/gky318
- [Google Scholar]
- Coordination chemistry of Ir with chelating ligands containing a xanthine-derived, protic n-heterocyclic carbene (NHC) Moiety. Eur J Inorg Chem. 2022;2022 https://doi.org/10.1002/ejic.202200484
- [Google Scholar]
- Discovery Studio Visualizer. v21.1.0.20298. San Diego, CA, USA: Dassault Systèmes; 2021.
- Biscussi, B., Murray, A.P., 2022. New caffeine derivatives as multi-target agents for the therapy of Alzheimer’s disease. International electronic conference on synthetic organic chemistry international electronic conference on synthetic organic chemistry, pp. 62.
- Caffeine suppresses amyloid-ß levels in plasma and brain of Alzheimer’s disease transgenic mice. JAD. 2009;17:681-697. https://doi.org/10.3233/jad-2009-1071
- [Google Scholar]
- High blood caffeine levels in MCI linked to lack of progression to dementia. J Alzheimers Dis. 2012;30:559-572. https://doi.org/10.3233/JAD-2012-111781
- [Google Scholar]
- Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer’s disease. J Nutr Health Aging. 2014;18:383-392. https://doi.org/10.1007/s12603-014-0021-7
- [Google Scholar]
- Molecular docking and simulation studies of antiviral compounds against to fowl adenovirus type 4 receptor from Psittacine bird Melopsittacus undulates. Microb. Pathog.. 2023;181:106208. https://doi.org/10.1016/j.micpath.2023.106208
- [Google Scholar]
- Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures. Alz Res Therapy. 2014;6 https://doi.org/10.1186/alzrt269
- [Google Scholar]
- SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep.. 2017;7:42717. https://doi.org/10.1038/srep42717
- [Google Scholar]
- GaussView, Version 6.0. Shawnee Mission, KS, USA: Semichem Inc.; 2016. n.d.
- Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer’s mice and cells. Neuropharmacology. 2012;63:1368-1379. https://doi.org/10.1016/j.neuropharm.2012.08.018
- [Google Scholar]
- A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88-95. https://doi.org/10.1016/0006-2952(61)90145-9
- [Google Scholar]
- A new 2,2’-oxydianiline derivative symmetrical azomethine compound containing thiophene units: Synthesis, spectroscopic characterization (UV–Vis, FTIR, 1 H and 13 C NMR) and DFT calculations. J Mol Struct. 2018;1168:115-126. https://doi.org/10.1016/j.molstruc.2018.05.021
- [Google Scholar]
- Caffeine as a protective factor in dementia and Alzheimer’s disease. JAD. 2010;20:S167-S174. https://doi.org/10.3233/jad-2010-1404
- [Google Scholar]
- Synthesis and analysis (thermodynamic, electronic, NLO, FMO, NBO, MEP, IR, UV, NMR properties, Hirshfeld surface analysis and molecular docking) of the new Schiff base molecule: (Z)-4 bromo-2-(((2,4-dimethoxypheny)limino)methyl)-5-fluorophenol. J Mol Struct. 2025;1329:141454. https://doi.org/10.1016/j.molstruc.2025.141454
- [Google Scholar]
- New synthetic caffeine analogs as modulators of the cholinergic system. Mol Pharmacol. 2022;101:154-167. https://doi.org/10.1124/molpharm.121.000415
- [Google Scholar]
- A novel pharmacological activity of caffeine in the cholinergic system. Neuropharmacology. 2018;135:464-473. https://doi.org/10.1016/j.neuropharm.2018.03.041
- [Google Scholar]
- Synthesis and antioxidant and antitumor activity of novel pyridine, chromene, thiophene and thiazole derivatives. Arch Pharm (Weinheim). 2012;345:378-385. https://doi.org/10.1002/ardp.201100335
- [Google Scholar]
- Gaussian 09, Revision B.01. Gaussian 09, Revision B.01. Wallingford CT: Gaussian, Inc.; 2009. p. :1-20. citeulike-article-id:9096580
- MicroRNA-based multi-target approach for Alzheimer’s disease: Discovery of the first-in-class dual inhibitor of acetylcholinesterase and MicroRNA-15b biogenesis. J Med Chem. 2020;63:9695-9704. https://doi.org/10.1021/acs.jmedchem.0c00756
- [Google Scholar]
- Disease-modifying drugs in Alzheimer’s disease. Drug Des Devel Ther. 2013;6:1471-1478. https://doi.org/Disease-modifying drugs in Alzheimer’s disease.
- [Google Scholar]
- Protective effect of chronic caffeine intake on gene expression of brain derived neurotrophic factor signaling and the immunoreactivity of glial fibrillary acidic protein and Ki-67 in Alzheimer’s disease. Int J Clin Exp Pathol. 2015;8:7710-7728.
- [Google Scholar]
- GraphPad Prism version 9.0.1 for Windows. USA: GraphPad Software, San Diego, California; n.d..
- Butyrylcholinesterase: An important new target in Alzheimer’s disease therapy. Int Psychogeriatr. 2002;14:77-91. https://doi.org/10.1017/s1041610203008676
- [Google Scholar]
- Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer ß-amyloid peptide in rodent. Proc Natl Acad Sci USA. 2005;102:17213-17218. https://doi.org/10.1073/pnas.0508575102
- [Google Scholar]
- Preparation and antioxidant activity of a-pyridoin and its derivatives. Bioorg Med Chem. 2005;13:6763-6770. https://doi.org/10.1016/j.bmc.2005.07.065
- [Google Scholar]
- Exploring the anti-Alzheimer potential: Design, synthesis, biological activity, and molecular docking study of benzothiazol-1,3,4-oxadiazole-acetamide compounds. J Mol Struct. 2024;1318:139307. https://doi.org/10.1016/j.molstruc.2024.139307
- [Google Scholar]
- New thiazole, pyridine and pyrazole derivatives as antioxidant candidates: Synthesis, DFT calculations and molecular docking study. Heliyon. 2020;6:e03185. https://doi.org/10.1016/j.heliyon.2020.e03185
- [Google Scholar]
- Synthesis, antibacterial and antioxidant activities of new 1-alkyl-4-(1-alkyl-4-oxo-1,4-dihydroquinolin-2-yl)pyridinium bromides. Eur J Med Chem. 2013;69:348-355. https://doi.org/10.1016/j.ejmech.2013.08.050
- [Google Scholar]
- Docking-based virtual screening using PyRx tool: Autophagy target Vps34 as a case study. In: Molecular docking for computer-aided drug design Molecular docking for computer-aided drug design. Elsevier; p. :463-477. https://doi.org/10.1016/b978-0-12-822312-3.00019-9
- [Google Scholar]
- Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer’s disease. Chemi-Biol Interact. 2025;420:111670. https://doi.org/10.1016/j.cbi.2025.111670
- [Google Scholar]
- Infrared and Raman spectroscopy, principles and spectral interpretation (2nd ed.). USA : Elsevier; 2018. p. :276p.
- Novel amino-pyridine functionalized chitosan quaternary ammonium derivatives: Design, synthesis, and antioxidant activity. Molecules. 2017;22:156. https://doi.org/10.3390/molecules22010156
- [Google Scholar]
- The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A1 and A2A receptors. Biochem Pharmacol. 2019;166:313-321. https://doi.org/10.1016/j.bcp.2019.06.008
- [Google Scholar]
- Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology. 2021;190:108352. https://doi.org/10.1016/j.neuropharm.2020.108352
- [Google Scholar]
- Caffeine and its antioxidant properties—It is all about dose and source. IJMS. 2022;23:13074. https://doi.org/10.3390/ijms232113074
- [Google Scholar]
- Özkay, Y., Osmaniye, D., Levent, S., Saglik, B.N., 2017. Novel imidazole derivatives as antifungal agents: Synthesis, biological evaluation, ADME prediction and molecular docking studies. The molecules medicinal chemistry symposium Molecules Med Chem Symp pp. 663.
- New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation. Eur J Med Chem. 2017;141:197-210. https://doi.org/10.1016/j.ejmech.2017.09.022
- [Google Scholar]
- Molecular docking: Shifting paradigms in drug discovery. Int J Mol Sci. 2019;20:4331. https://doi.org/10.3390/ijms20184331
- [Google Scholar]
- Thieno[2,3-b]pyridine amines: Synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer’s disease. Archiv der Pharmazie. 2020;353 https://doi.org/10.1002/ardp.202000101
- [Google Scholar]
- Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats. Neuropharmacology. 2013;64:153-159. https://doi.org/10.1016/j.neuropharm.2012.07.010
- [Google Scholar]
- Design, synthesis, and structure–activity relationship of caffeine-based triazoles as dual AChE and BACE-1 inhibitors. Drug Dev Res. 2022;83:1803-1821. https://doi.org/10.1002/ddr.21998
- [Google Scholar]
- Araucaria heterophylla oleogum resin essential oil is a novel aldose reductase and butyryl choline esterase enzymes inhibitor: In vitro and in silico evidence. Sci Rep. 2023;13:11446. https://doi.org/10.1038/s41598-023-38143-4
- [Google Scholar]
- Infrared spectroscopy: Fundamentals and applications. JohnWilley & Sons; 2004.
- Crystal structure and spectroscopic characterization of (E)-2-(((4-bromo-2-(trifluoromethoxy)phenyl)imino)methyl)-4-nitrophenol: A combined experimental and computational study. J Mol Struct. 2014;1063:295-306. https://doi.org/10.1016/j.molstruc.2014.01.079
- [Google Scholar]
- Synthesis of Iridium(III) and Rhodium(III) complexes bearing C8-metalated theophylline ligands by directed c–H activation. Organometallics. 2019;38:2250-2258. https://doi.org/10.1021/acs.organomet.9b00184
- [Google Scholar]
- Software news and update AutoDock Vina : Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009;31:455-461. https://doi.org/10.1002/jcc
- [Google Scholar]
- Synthesis of Iridium(III) and Rhodium(III) Complexes Bearing C8-Metalated Theophylline Ligands by Directed CH Activation. Organometallics. 2019;38:22502258.
- [Google Scholar]
- Cholinesterase inhibitors for the treatment of Alzheimer’s disease: Synthesis, biological analysis and molecular docking study of sulphur containing heterocyclic analogues. Chem Data Collections. 2024;51:101132. https://doi.org/10.1016/j.cdc.2024.101132
- [Google Scholar]
- Synthesis of Novel Pyrazolo[3,4-b]pyridines with Affinity for beta-Amyloid Plaques. Molbank 2022:1.
- [Google Scholar]
- Mechanisms of potential antioxidant activity of caffeine. Radiat Phys Chem. 2020;174:108968. https://doi.org/10.1016/j.radphyschem.2020.108968
- [Google Scholar]
- Regioselective alkylation reaction of purines under microwave irradiation. J Heterocyclic Chem. 2022;59:597-602. https://doi.org/10.1002/jhet.4407
- [Google Scholar]
- Increased cerebrospinal fluid production as a possible mechanism underlying caffeine’s protective effect against Alzheimer’s disease. Int J Alzheimer’s Dis. 2011;2011 https://doi.org/10.4061/2011/617420
- [Google Scholar]
- Neurotransmitters in prevention and treatment of Alzheimer’s disease. IJMS. 2023;24:3841. https://doi.org/10.3390/ijms24043841
- [Google Scholar]
- The potential of caffeine for functional modification from cortical synapses to neuron networks in the brain. Curr Neuropharmacol. 2005;3:309-316. https://doi.org/10.2174/157015905774322543
- [Google Scholar]
- Synthesis, spectroscopic characterization of new series of alizarin derivatives and their anti-microbial activities: DFT and molecular docking approach. J Mol Struct. 2022;1256:132527. https://doi.org/10.1016/j.molstruc.2022.132527
- [Google Scholar]
- Design, synthesis and biological evaluation of novel copper-chelating acetylcholinesterase inhibitors with pyridine and N-benzylpiperidine fragments. Bioorg Chem. 2019;93:103322. https://doi.org/10.1016/j.bioorg.2019.103322
- [Google Scholar]
- Inhibiting aß toxicity in Alzheimer’s disease by a pyridine amine derivative. Eur J Med Chem. 2019;168:330-339. https://doi.org/10.1016/j.ejmech.2019.02.052
- [Google Scholar]
